Neurological Manifestations of SARS-CoV-2 Infection

Battaglini Denise, Premraj Lavienraj, Griffee Matthew, Huth Samuel, Fanning Jonathon, Whitman Glenn, Bastos Porto Diego, Arora Rakesh, Durham Lucian, Gnall Eric, Amato Marcelo, Williams Virginie, Noel Alexandre, De Franca Sabrina Araujo, Samoukovic Gordan, Pujo Bambang, Kent David, Marwali Eva, Al-Fares Abdulrahman, Stecher Stephanie-Susanne, Panigada Mauro, Giani Marco, Foti Giuseppe, Pelosi Paolo, Pesenti Antonio, White Nicole Marie, Li Bassi Gianluigi, Suen Jacky, Fraser John F., Robba Chiara and Cho Sung-Min on behalf of the COVID-19 Critical Care Consortium Front. Med. DOI 10.3389/fmed.2022.930217

Introduction: Neurological manifestations and complications in coronavirus disease-2019 (COVID-19) patients are frequent. Prior studies suggested a possible association between neurological complications and fatal outcome, as well as the existence of potential modifiable risk factors associated to their occurrence. Therefore, more information is needed regarding the incidence and type of neurological complications, risk factors, and associated outcomes in COVID-19.